DK3679038T3 - Substituerede imidazoquinoliner - Google Patents

Substituerede imidazoquinoliner Download PDF

Info

Publication number
DK3679038T3
DK3679038T3 DK18759137.5T DK18759137T DK3679038T3 DK 3679038 T3 DK3679038 T3 DK 3679038T3 DK 18759137 T DK18759137 T DK 18759137T DK 3679038 T3 DK3679038 T3 DK 3679038T3
Authority
DK
Denmark
Prior art keywords
substituted imidazoquinolines
imidazoquinolines
substituted
Prior art date
Application number
DK18759137.5T
Other languages
English (en)
Inventor
Christophe Henry
Original Assignee
BioNTech SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNTech SE filed Critical BioNTech SE
Application granted granted Critical
Publication of DK3679038T3 publication Critical patent/DK3679038T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK18759137.5T 2017-09-06 2018-08-31 Substituerede imidazoquinoliner DK3679038T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2017/072352 WO2019048036A1 (en) 2017-09-06 2017-09-06 SUBSTITUTED IMIDAZOQUINOLINES
PCT/EP2018/073470 WO2019048350A1 (en) 2017-09-06 2018-08-31 SUBSTITUTED IMIDAZOQUINOLINES

Publications (1)

Publication Number Publication Date
DK3679038T3 true DK3679038T3 (da) 2024-05-27

Family

ID=59914433

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18759137.5T DK3679038T3 (da) 2017-09-06 2018-08-31 Substituerede imidazoquinoliner

Country Status (16)

Country Link
US (2) US11267813B2 (da)
EP (2) EP3679038B1 (da)
JP (1) JP7241738B2 (da)
KR (1) KR20200050963A (da)
CN (1) CN111094287A (da)
AU (1) AU2018327414B2 (da)
BR (1) BR112020004504A2 (da)
CA (1) CA3074166A1 (da)
DK (1) DK3679038T3 (da)
FI (1) FI3679038T3 (da)
IL (1) IL273002B2 (da)
MX (1) MX2020002367A (da)
RU (1) RU2768629C2 (da)
SG (1) SG11202001925WA (da)
WO (2) WO2019048036A1 (da)
ZA (2) ZA202001266B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020004505A2 (pt) * 2017-09-06 2020-09-15 BioNTech SE imidazoquinolinas substituídas como agonistas de tlr7
WO2019048036A1 (en) * 2017-09-06 2019-03-14 Biontech Ag SUBSTITUTED IMIDAZOQUINOLINES
US20220144822A1 (en) * 2019-03-07 2022-05-12 BioNTech SE Process for the preparation of a substituted imidazoquinoline
CN114599360A (zh) * 2019-10-29 2022-06-07 骏达贸易有限公司 4-氨基-咪唑并喹啉化合物及其用途
WO2023083439A1 (en) * 2021-11-09 2023-05-19 BioNTech SE Tlr7 agonist and combinations for cancer treatment

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS585623B2 (ja) 1976-07-12 1983-02-01 日本電信電話株式会社 ファクシミリ通信方式
JPS585623U (ja) 1981-07-01 1983-01-14 株式会社日立ホームテック ジヤ−式ガス炊飯器
US6573273B1 (en) 1999-06-10 2003-06-03 3M Innovative Properties Company Urea substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6451810B1 (en) 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6677349B1 (en) 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
EP1496896A4 (en) 2002-04-08 2007-10-31 Merck & Co Inc AKT INHIBITORS EFFECT
WO2005051324A2 (en) 2003-11-25 2005-06-09 3M Innovative Properties Company Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
JP5128940B2 (ja) * 2004-06-18 2013-01-23 スリーエム イノベイティブ プロパティズ カンパニー 置換イミダゾキノリン、イミダゾピリジン、およびイミダゾナフチリジン
WO2007056112A2 (en) * 2005-11-04 2007-05-18 Coley Pharmaceutical Group, Inc. Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
CA2676786C (en) 2007-02-20 2015-01-27 Novartis Ag Imidazoquinolines as dual lipid kinase and mtor inhibitors
MY150519A (en) * 2007-05-08 2014-01-30 Astrazeneca Ab Imidazoquinolines with immuno-modulating properties
NZ599446A (en) 2008-03-24 2013-11-29 4Sc Discovery Gmbh Novel substituted imidazoquinolines
WO2010119264A1 (en) 2009-04-16 2010-10-21 Centro Nacional De Investigaciones Oncólogicas (Cnio) Imidazopyrazines for use as kinase inhibitors
CN103012398B (zh) 2011-09-19 2015-10-14 上海恒瑞医药有限公司 咪唑并喹啉类衍生物及其可药用盐、其制备方法及其在医药上的应用
WO2019048036A1 (en) * 2017-09-06 2019-03-14 Biontech Ag SUBSTITUTED IMIDAZOQUINOLINES
BR112020004505A2 (pt) 2017-09-06 2020-09-15 BioNTech SE imidazoquinolinas substituídas como agonistas de tlr7

Also Published As

Publication number Publication date
ZA202001266B (en) 2021-08-25
CN111094287A (zh) 2020-05-01
RU2020112229A (ru) 2021-10-06
IL273002B2 (en) 2023-08-01
EP4403225A2 (en) 2024-07-24
JP2020532570A (ja) 2020-11-12
EP3679038B1 (en) 2024-04-03
US20200317663A1 (en) 2020-10-08
RU2768629C2 (ru) 2022-03-24
MX2020002367A (es) 2020-07-20
IL273002A (en) 2020-04-30
SG11202001925WA (en) 2020-04-29
US12054485B2 (en) 2024-08-06
US20220227756A1 (en) 2022-07-21
JP7241738B2 (ja) 2023-03-17
AU2018327414A1 (en) 2020-03-19
EP3679038A1 (en) 2020-07-15
FI3679038T3 (fi) 2024-05-23
WO2019048036A1 (en) 2019-03-14
CA3074166A1 (en) 2019-03-14
WO2019048350A1 (en) 2019-03-14
ZA202101322B (en) 2022-09-28
BR112020004504A2 (pt) 2020-09-15
RU2020112229A3 (da) 2021-10-06
KR20200050963A (ko) 2020-05-12
US11267813B2 (en) 2022-03-08
AU2018327414B2 (en) 2024-02-15
IL273002B1 (en) 2023-04-01

Similar Documents

Publication Publication Date Title
DK3731771T3 (da) V462033dk00
DK3319956T3 (da) Substituerede oxopyridinderivater
DE202018003363U8 (de) Handgelenkssphygmomanometer
CL2018000524S1 (es) Golilla
DK3351526T3 (da) Diisopentylterephthalat
DK3571580T3 (da) Load-logical-and-shift-guarded-instruktion
DK3568655T3 (da) Rekuperator
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
DK3679038T3 (da) Substituerede imidazoquinoliner
DK3612237T3 (da) Genterapi
DK3568506T3 (da) Offeranode
DK3645513T3 (da) Benzazepinderivater
DK3576686T3 (da) Brokbind
DK3676276T3 (da) Spirothietannukleosider
DK3395159T3 (da) Ballepresse
DK3576718T3 (da) Pastil
FI11704U1 (fi) Liittopuujärjestely
DK3510051T3 (da) Carboxylalkylchitosan
DK3391733T3 (da) Ballepresse
ES1205411Y (es) Maleta-Gaveta
ES1198359Y (es) Columbario
FI11529U1 (fi) Ontelolaatan kannake
DK3645955T3 (da) Buffertank
DK3401461T3 (da) Falsetagtegl
DK3391735T3 (da) Ballepresse